3-amino-3-deoxy-1,2:5,6-di-O-isopropylidene-α-D-glucofuranose

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 3-amino-3-deoxy-1,2:5,6-di-O-isopropylidene-α-D-glucofuranose
• 英文别名: (3AR,5S,6S,6aR)-5-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-6-amine；(3aR,5S,6S,6aR)-5-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-6-amine
• 化学式: C₁₂H₂₁NO₅
• 分子量: 259.302
• InChiKey: SHQAHGPRANRAGI-JDDHQFAOSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.3
• 重原子数：
  18
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  72.2
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  3-amino-3-deoxy-1,2:5,6-di-O-isopropylidene-α-D-glucofuranose 在 lithium aluminium tetrahydride 作用下， 以 1,4-二氧六环 、 吡啶 为溶剂， 反应 19.0h， 生成 (3aR,4aS,5R,7aS,7bR)-7-benzyl-2,2-dimethylhexahydro-5H-[1,3]dioxolo[4',5':4,5]furo[3,2-b]pyrrol-5-ol
  参考文献：
  名称：

  用氢化锂铝还原1,2; 5,6-二-O-异亚丙基-α-d-葡糖呋喃糖衍生物; 3,6-亚氨基衍生物的简便合成方法

  摘要：

  摘要在沸腾的1,4-二恶烷中用氢化铝锂处理3-酰氨基-或烷基亚氨基-3-脱氧-1,2; 5,6-二-O-异亚丙基-α-d-葡萄糖呋喃糖可得到不同寻常的产物，即3，6-N-烷基亚氨基-3，6-二氧-1,2-O-异亚丙基-α-d-葡糖呋喃糖或6-O-异丙基-1,2-O-异亚丙基-α-d-葡糖呋喃糖衍生物。通过该反应，制备了3，6-N-（苄氧基）亚氨基-3，6-二脱氧-1,2-O-异亚丙基-β-1-异呋喃糖，其是合成茴香霉素的关键中间体。

  DOI：

  10.1016/0008-6215(83)88284-6
• 作为产物：
  描述：

  1,2,5,6-di-O-isopropylidene-α-D-glucofuranose-3-O-(S-methylxanthate) 在 2(1H)-吡啶硫酮,1-(乙酰氧基)- 、 硼酸 作用下， 以 乙醇 、 二氯甲烷 、 水 为溶剂， 生成 3-amino-3-deoxy-1,2:5,6-di-O-isopropylidene-α-D-glucofuranose
  参考文献：
  名称：

  Nitrogen transfer to carbon radicals

  摘要：

  DOI：

  10.1021/ja00040a088

文献信息

• MONOSACCHARIDE DERIVATIVES
  申请人：Sattigeri Jitendra Viswajanani

  公开号：US20080114031A1

  公开（公告）日：2008-05-15

  The present invention relates to monosaccharide derivatives as anti-inflammatory agents. The compounds disorder herein can be useful for inhibition and prevention of inflammation and associated pathologies including inflammatory and autoimmune diseases such as bronchial asthma, rheumatoid arthritis, type I diabetes, multiple sclerosis, allograft rejection, psoriasis, inflammatory bowel disease, Ulcerative colitis, acne, atherosclerosis, cancer, pruritis and allergic rhinitis. Pharmacological compositions containing compounds disclosed herein and the methods of treating bronchial asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, multiple sclerosis, type I diabetes, psoriasis, allograft rejection, inflammatory bowel disease, Ulcerative colitis, acne, atherosclerosis, cancer, pruritis, allergic rhinitis and other inflammatory and/or autoimmune disorders, using the compounds are also provided.

  本发明涉及单糖衍生物作为抗炎剂。本发明的化合物可用于抑制和预防炎症及相关病理，包括炎症和自身免疫疾病，如支气管哮喘、类风湿性关节炎、I型糖尿病、多发性硬化症、异体移植排斥、银屑病、炎症性肠病、溃疡性结肠炎、痤疮、动脉粥样硬化、癌症、瘙痒和过敏性鼻炎。还提供了包含本发明披露的化合物的药物组合物，以及使用这些化合物治疗支气管哮喘、慢性阻塞性肺病、类风湿性关节炎、多发性硬化症、I型糖尿病、银屑病、异体移植排斥、炎症性肠病、溃疡性结肠炎、痤疮、动脉粥样硬化、癌症、瘙痒、过敏性鼻炎以及其他炎症性和/或自身免疫障碍的方法。
• Asymmetric α-Alkylation of α-Amino Esters Using Pyridoxal Derivatives Having a Chiral Ansa-Structure and a Chiral Ionophore Function: a Novel Example of Double Asymmetric Induction
  作者：Kazuyuki Miyashita、Hideto Miyabe、Kuninori Tai、Hiroshi Iwaki、Takeshi Imanishi

  DOI：10.1016/s0040-4020(00)00392-6

  日期：2000.6

  Stereoselective alkylation of aldimines, prepared from α-amino esters and a pyridoxal model having a chiral ansa-structure and an ethoxyethoxy group at C-3, proceeded in the presence of Li+ to give α,α-dialkyl amino esters after acidic hydrolysis. Double asymmetric induction effect was also observed in the alkylation reaction by combination of the chiral ansa-structure and a chiral ionophore side chain

  由α-氨基酯和在C-3上具有手性ansa结构和乙氧基乙氧基的吡ido醛模型制备的醛亚胺的立体选择性烷基化在Li +存在下进行，在酸性水解后得到α，α-二烷基氨基酯。通过手性ansa结构和C-3处的手性离子载体侧链的组合，在烷基化反应中还观察到双重不对称诱导作用。
• Monosaccharide Derivatives as Anti-Inflammatory and/or Anti-Cancer Agents
  申请人：Sattigeri Vishwajanani Jitendra

  公开号：US20090048186A1

  公开（公告）日：2009-02-19

  The present invention relates to monosaccharide derivatives as anti-inflammatory agents. The compounds disorder herein can be useful for inhibition and prevention of inflammation and associated pathologies including inflammatory and autoimmune diseases such as bronchial asthma, rheumatoid arthritis, type I diabetes, multiple sclerosis, allograft rejection, psoriasis, inflammatory bowel disease, ulcerative colitis, acne, atherosclerosis, cancer, pruritis and allergic rhinitis. Pharmacological compositions containing compounds disclosed herein and the methods of treating bronchial asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, multiple sclerosis, type I diabetes, psoriasis, allograft rejection, inflammatory bowel disease, ulcerative colitis, acne, atherosclerosis, cancer, pruritis, allergic rhinitis and other inflammatory and/or autoimmune disorders, using the compounds are also provided.

  本发明涉及单糖衍生物作为抗炎剂。本发明的化合物可用于抑制和预防炎症及相关病理，包括炎症和自身免疫疾病，如支气管哮喘、类风湿性关节炎、I型糖尿病、多发性硬化症、异体移植排斥、银屑病、炎症性肠病、溃疡性结肠炎、痤疮、动脉粥样硬化、癌症、瘙痒和过敏性鼻炎。还提供了含有本发明披露的化合物的药物组合物，以及使用这些化合物治疗支气管哮喘、慢性阻塞性肺病、类风湿性关节炎、多发性硬化症、I型糖尿病、银屑病、异体移植排斥、炎症性肠病、溃疡性结肠炎、痤疮、动脉粥样硬化、癌症、瘙痒、过敏性鼻炎以及其他炎症性和/或自身免疫障碍的方法。
• Monosaccharide derivatives as anti-inflammatory agents
  申请人：Ranbaxy Laboratories Limited

  公开号：EP1953170A1

  公开（公告）日：2008-08-06

  The present invention relates to monosaccharide derivatives as anti-inflammatory agents. The compounds disclosed herein can be useful for inhibition and prevention of inflammation and associated pathologies including inflammatory, cancer, cardiovascular and autoimmune diseases such as bronchial asthma, rheumatoid arthritis, type-I diabetes, multiple sclerosis, allograft rejection, psoriasis, inflammatory bowel disease, ulcerative colitis, acne, atherosclerosis, pruritis or allergic rhinitis. Pharmacological compositions containing compounds disclosed herein and the methods of treating diseases such as bronchial asthma, rheumatoid arthritis, type-I diabetes, multiple sclerosis, cancer, cardiovascular diseases, allograft rejection, psoriasis, inflammatory bowel disease, ulcerative colitis, acne, atherosclerosis, pruritis or allergic rhinitis and other inflammatory and/or autoimmune disorders, using the compounds are also provided.

  本发明涉及单糖衍生物作为抗炎药剂。本文披露的化合物可用于抑制和预防炎症及相关病理，包括炎症性、癌症、心血管和自身免疫疾病，如支气管哮喘、类风湿关节炎、I型糖尿病、多发性硬化症、移植排斥、牛皮癣、炎症性肠病、溃疡性结肠炎、痤疮、动脉粥样硬化、瘙痒或过敏性鼻炎。还提供了含有本文披露的化合物的药理组合物和治疗支气管哮喘、类风湿关节炎、I型糖尿病、多发性硬化症、癌症、心血管疾病、移植排斥、牛皮癣、炎症性肠病、溃疡性结肠炎、痤疮、动脉粥样硬化、瘙痒或过敏性鼻炎等疾病的方法，以及使用这些化合物治疗其他炎症性和/或自身免疫性疾病的方法。
• Regioselective synthesis of chiral six- and seven-membered N-heterocycles from N-allyl carbohydrate nitrones: Tuning of regioselectivity by N-substitution
  作者：Swapan Majumdar、Anup Bhattacharjya、Amarendra Patra

  DOI：10.1016/s0040-4020(99)00694-8

  日期：1999.10

  The intramolecular cycloaddition of N-allyl carbohydrate nitrones leads to enantiomerically pure six- and seven-membered nitrogen heterocycles and the regioselectivity of the cycloaddition was controlled by changing the substituent on the nitrogen atom of the N-allyl moiety.

  N-烯丙基碳水化合物硝酮的分子内环加成导致对映体纯的六元和七元氮杂环，并且通过改变N-烯丙基部分的氮原子上的取代基来控制环加成的区域选择性。